药品注册管理办法 6个附件英文版

上传人:灯火****19 文档编号:125132773 上传时间:2020-03-15 格式:DOC 页数:57 大小:536.50KB
返回 下载 相关 举报
药品注册管理办法 6个附件英文版_第1页
第1页 / 共57页
药品注册管理办法 6个附件英文版_第2页
第2页 / 共57页
药品注册管理办法 6个附件英文版_第3页
第3页 / 共57页
药品注册管理办法 6个附件英文版_第4页
第4页 / 共57页
药品注册管理办法 6个附件英文版_第5页
第5页 / 共57页
点击查看更多>>
资源描述

《药品注册管理办法 6个附件英文版》由会员分享,可在线阅读,更多相关《药品注册管理办法 6个附件英文版(57页珍藏版)》请在金锄头文库上搜索。

1、Annex 1: Registration Categories and Application InformationRequirements of TCM and Natural Drugs Traditional Chinese Medicine (TCM) of thisannex refer to the medical substance and its preparation used under the guidance of Chinese traditional medical theory. Natural Drugs of this annex refer to the

2、 medical natural substance and its preparation used under the guidance of modern medical theory. Part I Registration Categories and notes I Registration Categories 1. active ingredients and its preparation extracted from plant, animal and minerals, which have not been marketed in China. 2. newly fou

3、nd drug material and preparations; 3. new TCM substitute 4. new part of drug material to be used as drugs, 5. new active part of material to be used as drugs and its preparation, which are extracted from plant, animal and minerals and have not been marketed in China; 6. TCM, natural drugs and its co

4、mbined preparation not yet marketed in China 7. preparations with change in route of administration of the TCM or natural drugs already marketed in China, 8. preparations with change in dosage form of the TCM or natural drugs already marketed in China, 9. generic drugs. II Notes Drug under category

5、1-6 refers to as new drugs, while procedure for new drugs is applicable for the new drug under category 7 and 8. 1. “active ingredients and its preparation extracted from plant, animal and minerals, which have not been marketed in China” refer to the single component or its preparation, which are ex

6、tracted from plant, animal and minerals and not yet collected into National Drug Standards, where the content of this single component should be more than 90% of the extraction. 2. “newly found drug material and preparations” refer to the drug material and preparations not yet collected into Nationa

7、l Drug Standard or provincial drug formulary (statutory standards)3. “new TCM substitute” refer to drug material used to substitute the toxic drug material of the formula in the National Drug Standard or the endangered drug material, which is not yet collected by statutory standards. 4. “new part of

8、 drug material to be used as drugs” refer to the new part of existing drugs of animals or plants, which is to be used as drug, while the existing drugs is already in the statutory standards. 5. “new active part of material to be used as drugs and its preparation, which are extracted from plant, anim

9、al and minerals and have not been marketed in China” refer to active parts of similar or multiple component and its preparation, which are extracted from plant, animal and minerals, and not yet collected in National Drug Standards, where the active part should be more than 50% of the extraction. 6.

10、“TCM, natural drugs and its combined preparation not yet marketed in China” include 6.1 combined preparation of TCM 6.2 combined preparation of natural drugs, 6.3 combined preparation of TCM, natural drugs and chemical drugs combined preparation of TCM should be formulated under traditional Chinese

11、medical theory, including, combined preparation of TCM from ancient classic formula, combined preparation with indication of ancient term, or combined preparation with combined term. combined preparation of natural drugs should be formulated under modern medical theory, where indication should be in

12、 modern medical term. combined preparation of TCM, natural drugs and chemical drugs include combined preparation of TCM and chemical drugs, combined preparation of natural drugs and chemical drugs, and combined preparation of TCM, natural drugs and chemical drugs 7. “preparations with change in rout

13、e of administration of the TCM or natural drugs already marketed in China,” refers to the preparation with transfer between route of administration or absorption location. 8. “preparations with change in dosage form of the TCM or natural drugs already marketed in China” refer to the preparation of c

14、hange in dosage form but with no change in route of administration. 9. “Generic drug” refer to the registration application of TCM or natural drug already approved to be marketed in China II Application Information Items and notesA Application Information Items Summary information 1) Name of the dru

15、gs. 2) Certified Documents. 3) Objectives and basis for the application. 4) Summary and evaluation of main research results. 5) Sample draft of insert sheet, notes to the draft, and literature. 6) Sample design for packing, label.Pharmaceutical Study Information 7) Summary of Pharmaceutical Study In

16、formation. 8) Source of the drug and determination. 9) Ecological environment, identity, description, cultivation, and growing method, local processing and preparing. 10) Draft of standard of drug material, and note of drafting, with provision of drug standard material and related information. 11) Sample of plant or mine

展开阅读全文
相关资源
正为您匹配相似的精品文档
相关搜索

最新文档


当前位置:首页 > 办公文档 > 规章制度

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号